Table 3.
Summary of statistical trends of FLIM-derived features in Moderate and High-Grade Dysplasia/SCC vs. Normal. TRFS:Time-Resolved Fluorescence Spectroscopy; FLIM:Fluorescence Lifetime Imaging; MPM-FLIM:Multiphoton FLIM; AFS:Autofluorescence Spectroscopy; CFM:Confocal Fluorescence Microscopy; SLS:Synchronous Luminescence Spectroscopy
| Emission Channel | Associated Fluorophore | FLIM-Derived Autofluorescence Features | Moderate and High-Grade Dysplasia / SCC vs. Normal | |
|---|---|---|---|---|
| Observed Trend | Previous Studies [Ref.] | |||
| ↓ In Vivo AFS: Hamsters [33] | ||||
| I390 | ↓ | ↓ Ex Vivo CFM: Patients [20] | ||
| I390,n | ↓ | ↓ Ex Vivo SLS: Patients [31] | ||
| ↓ In Vivo FLIM: Hamsters [32] | ||||
| 390 ± 20 nm | Collagen | ↓ In Vivo TRFS: Patients [25] | ||
| τa,v,g,390 | ↓ | Not Reported | ||
| αfast,390 | No Change | Not Reported | ||
| τfast,390 | ↓ | Not Reported | ||
| τslow,390 | ↓ | Not Reported | ||
| ↓ In Vivo FLIM: Patients [2] | ||||
| I452 | ↓ | ↓ In Vivo AFS: Hamsters [33] | ||
| I452,n | ↓ | ↓ Ex Vivo SLS: Patients [31] | ||
| 452 ± 22.5 nm | NADH | τa,v,g,452 | ↓ | ↓ In Vivo TRFS: Patients [25] |
| ↓ In Vivo FLIM: Patients [2] | ||||
| ↓ In Vivo FLIM: Hamsters [32] | ||||
| ↓ Ex Vivo FLIM: Patients [24] | ||||
| ↓ In Vivo TRFS: Patients [25] | ||||
| αfast,452 | ↑ | Not Reported | ||
| τfast,452 | ↓ | ↓ In Vivo MPM-FLIM: Hamsters [18] | ||
| ↓ Ex Vivo TRFS: Patients [23] | ||||
| τslow,452 | No Change | ↓ In Vivo MPM-FLIM: Hamsters [18] | ||
| ↑ In Vivo AFS: Hamsters [33] | ||||
| I500 | ↓ | ↑ Ex Vivo CFM: Patients [20] | ||
| I500,n | ↑ | ↑ Ex Vivo SLS: Patients [31] | ||
| ↑ In Vivo TRFS: Patients [25] | ||||
| > 500 nm | FAD | τavg,500 | ↑ | ↓ Ex Vivo FLIM: Patients [24] |
| αfast,500 | ↑ | ↓ In Vivo MPM-FLIM: Hamsters [18] | ||
| τfast,500 | No Change | ↑ In Vivo MPM-FLIM: Hamsters [18] | ||
| τslow,500 | ↑ | Not Reported | ||
| 452 / 500 nm | Redox-Ratio = NADH / FAD | I452/I500 | ↓ | ↓ In Vivo AFS: Hamsters [33] |
| ↓ Ex Vivo FLIM: Patients [24] | ||||